Therapeuticsmd Inc (TXMD)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Therapeuticsmd Inc-Aktie (TXMD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	17.65% 0.784	0.952	0.393	0.667	0.547
Operating Expenses	0.06% 1.646	1.647	1.264	0.986	1.406
Benefits Costs and Expenses	80.34% 0.734	0.407	1.061	0.584	1.114
Costs And Expenses	80.34% 0.734	0.407	1.061	-1.431	1.406
Depreciation and Amortization	0.00% 0.096	0.096	0.095	0.10	0.096
Operating Income/Loss	24.03% -0.862	-0.695	-0.871	-0.319	-0.859
Nonoperating Income/Loss	26.45% 0.912	1.24	0.203	0.402	0.292
Income/Loss From Continuing Operations Before Tax	90.83% 0.05	0.545	-0.668	0.083	-0.567
Income Tax Expense/Benefit	-	-	-0.032	-	-
Income/Loss From Continuing Operations After Tax	90.83% 0.05	0.545	-0.636	0.114	-0.567
Income/Loss From Discontinued Operations, Net Of Tax	1,600% 0.102	0.006	-0.017	0.138	-0.042
Net Income/Loss	72.41% 0.152	0.551	-0.653	0.252	-0.609
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.00% 11.57	11.57	11.55	-11.52	11.53
Diluted Average Shares	0.00% 11.57	11.57	11.55	-11.52	11.53
Basic Earnings Per Share	80.00% 0.01	0.05	-0.06	0.02	-0.05
Diluted Earnings Per Share	80.00% 0.01	0.05	-0.06	0.02	-0.05
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ALKS

$49.06

0.79%

RDY

$12.27

1.21%

ELAN

$23.67

5.15%

NBIX

$152.72

1.26%

VTRS

$16.23

1.18%

UTHR

$499.73

0.31%